| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/02/2003 | EP1267932A1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
| 01/02/2003 | EP1267925A1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 01/02/2003 | EP1267924A2 Immunotherapeutic methods and compositions |
| 01/02/2003 | EP1267923A1 Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical composition administered by mucosal delivery |
| 01/02/2003 | EP1267921A1 Composition and method for the prevention and/or the treatment of allergy |
| 01/02/2003 | EP1267918A1 Method of treatment using ligand-immunogen conjugates |
| 01/02/2003 | EP1267913A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 01/02/2003 | EP1267900A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 01/02/2003 | EP1267898A2 Bile acid containing prodrugs with enhanced bioavailability |
| 01/02/2003 | EP1267894A2 Viscoelastics for use in middle ear surgery |
| 01/02/2003 | EP1267890A2 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity |
| 01/02/2003 | EP1267889A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 01/02/2003 | EP1267884A1 Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients |
| 01/02/2003 | EP1267880A1 Low dose entecavir formulation and use |
| 01/02/2003 | EP1267879A2 Sustained release beadlets containing stavudine |
| 01/02/2003 | EP1267866A2 The treatment of respiratory diseases |
| 01/02/2003 | EP1267865A2 Amiodarone-containing parenteral solution |
| 01/02/2003 | EP1267864A1 A synergistic anti-malarial formulation |
| 01/02/2003 | EP1267846A1 Transdermal therapeutic system for the delivery of lerisetron |
| 01/02/2003 | EP1267845A1 Plaster containing an active agent |
| 01/02/2003 | EP1267843A1 System for transporting active substances in a biological system |
| 01/02/2003 | EP1267842A1 Method for producing a controlled-release preparation |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267838A1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267836A1 Process for the preparation of accelerated release formulations using compressed fluids |
| 01/02/2003 | EP1267835A1 D and l etherlipid stereoisomers and liposomes |
| 01/02/2003 | EP1267834A1 Cationic liposomes |
| 01/02/2003 | EP1267832A1 New self emulsifying drug delivery system |
| 01/02/2003 | EP1267831A1 New self emulsifying drug delivery system |
| 01/02/2003 | EP1267829A1 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 01/02/2003 | EP1267828A2 Pharmaceutical preparations |
| 01/02/2003 | EP1267827A2 Method for treating dry eye |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267806A2 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| 01/02/2003 | EP1267803A2 Compositions and methods for treating hair loss using c 16? - c 20? aromatic tetrahydro prostaglandins |
| 01/02/2003 | EP1267634A1 Digestable chewing gum |
| 01/02/2003 | EP1267622A2 Anthelmintic combinations |
| 01/02/2003 | EP1113798B1 Topical formulation of alkyl-, phenyl-pyridone |
| 01/02/2003 | EP1105102B1 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt |
| 01/02/2003 | EP1098935B1 Coating and excipient agent for oral or dermal dosage forms |
| 01/02/2003 | EP0999853B1 Stabilized antibody formulation |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0776329B1 Water-soluble polyene conjugate |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/02/2003 | EP0723440B1 Therapeutic delivery compositions and methods of use thereof |
| 01/02/2003 | EP0628074B1 In vitro activation of cytotoxic t cells |
| 01/01/2003 | CN1388760A Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 01/01/2003 | CN1388758A Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 01/01/2003 | CN1388757A Bioavailable dosage form of isotretinoin |
| 01/01/2003 | CN1388190A Dis-coating composition containing starch or starch gum |
| 01/01/2003 | CN1388189A Dip-coating composition containing cellulose ether |
| 01/01/2003 | CN1388131A Serial medicine carriers, tyrosine hydrozylase fusion protein as new carrier and its prepn |
| 01/01/2003 | CN1387925A Plant candle for ear and its prepn |
| 01/01/2003 | CN1387915A Plaster matrix and its prepn |
| 01/01/2003 | CN1097619C Moisture barrier film coating composition, its producing method and coating products |
| 01/01/2003 | CN1097467C Vaccine compositions |
| 01/01/2003 | CN1097458C Stable oil-in-water emulsions containing taxine (taxol) and its producing process |
| 01/01/2003 | CN1097455C New aqueous medicament preparation for the production of propellent gas-free acrosols |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500918 Conjugate comprising an antinociceptive agent covalently bonded to a blood component |
| 12/31/2002 | US6500916 Hydrozino and saccharide modified and drug bonded polyglutamic acid; drug delivery systems into target organs |
| 12/31/2002 | US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
| 12/31/2002 | US6500862 Nonsettling mixtures of oleic, linoleic and palmitoleic acids, diethylene glycol, diethyl ether, n-methylpyrrolidone, polyethers, sodium laury sulfate, isopropanol, water and attractants having storage stability and chemical resistance |
| 12/31/2002 | US6500861 Elimination of bacteria, spores and fungi from urogenital or gastrointerstinal systems by washing with mixtures of caproic, caprylic, capric, lauric, citric, acetic or fumaric acids, anionic surfactants and water |
| 12/31/2002 | US6500800 Composition and method for causing photodynamic damage to target cells |
| 12/31/2002 | US6500669 For selectively killing a subpopulation of cells in a heterogenous cell population; alkylating agents or heavy metal coordination compounds linked to a compound that binds to steroid receptor |
| 12/31/2002 | US6500646 Drugs in which peptides having affinity specific for phospholipids, preferably those which are contained in the constituents of lipid bilayers forming the surface layers of cells and of which the proportion in the outer part of each |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500472 For enriching foods or beverages, anemia treatment |
| 12/31/2002 | US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500466 Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use |
| 12/31/2002 | US6500463 Mixing plasticizable matrix material, liquid plasticizer, encapsulant, non-plasticizable non-gelatinized starch, and component for controlling rate of release of encapsulant under low shear and low temperature, forming into pieces, drying |
| 12/31/2002 | US6500462 Edible MCC/PGA coating composition |
| 12/31/2002 | US6500461 Core comprising poorly hydrophilic compound, conjugate of biocompatible hydrophilic domain and biocompatible hydrophobic domain, conjugate surrounding core |
| 12/31/2002 | US6500456 Compressed nitroglycerin tablet and its method of manufacture |
| 12/31/2002 | US6500455 Coating crystalline, racemic tolperisone in coating column which is operated with air flow with mixture of methanol and solution of synthetic, semisynthetic or natural hydrogels in chloroform to produce delayed release preparation |
| 12/31/2002 | US6500454 Dosage form of timed, sustained release beads comprising core particle of propranolol coated with ethyl cellulose membrane to sustain drug release and outer membrane comprising mixture of ethyl cellulose and enteric polymer providing lag time |
| 12/31/2002 | US6500450 Composition for treating migraine headaches |
| 12/31/2002 | US6500448 Composition comprising biocompatible polymer matrix having particles of metal cation-complexed human growth hormone dispersed therein, and aqueous injection vehicle comprising low viscosity sodium carboxymethyl cellulose |
| 12/31/2002 | US6500446 Composition for skin treatment comprising pharmaceutically or cosmetically acceptable medium with dispersed cationic polysaccharide and microparticles or nanoparticles containing at least one biologically active molecule; synergistic |
| 12/31/2002 | US6500440 Preparation comprising alprostadil in oily vehicle with skin permeation enhancer, anti-irritant agent and thickener |
| 12/31/2002 | US6500436 Administering botulinium toxin component coupled to substance p |
| 12/31/2002 | US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain |
| 12/31/2002 | US6500411 A particulate material and a natural polymer free of carboxymethyl cellulose or xanthan gum for addtion to a formulation including a hydrophilic liquid selected from water, a hydrophilic organic liquid, and mixture; sunscreen |
| 12/31/2002 | US6500409 Oral antigingivitis composition comprising an orally acceptable vehicle of a combination of a noncationic halogenated hydroxydiphenyl ether and an extract of magnolia cortex, the bark of magnolia officinalis such as magnolol |
| 12/31/2002 | CA2097732C Composition comprising r-alpha-lipoic acid and vitamin e for treating diabetes mellitus |
| 12/31/2002 | CA2044812C Radiopharmaceutical formulations, their method of administration and process of preparation |
| 12/29/2002 | CA2392383A1 A complex comprising ocif and polysaccharide |
| 12/27/2002 | WO2002103029A2 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 12/27/2002 | WO2002103004A1 Surface modification for improving biocompatibility |
| 12/27/2002 | WO2002102996A1 Male contraceptives |
| 12/27/2002 | WO2002102825A2 Fluorescently labelled locked nucleic acids |
| 12/27/2002 | WO2002102445A1 Dry powder inhalation system for transpulmonary administration |
| 12/27/2002 | WO2002102432A1 Biofunctional fibers |
| 12/27/2002 | WO2002102414A1 Medicinal compositions |
| 12/27/2002 | WO2002102413A2 Alkali or alkaline earth metal benzoate particles |
| 12/27/2002 | WO2002102391A2 Composition comprising nanoparticulate spironolactone |